References:
1 Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin . 2015-03-01 2015;65(2):87-108.
2 Shield KD, Ferlay J, Jemal A, et al. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin . 2017-01-01 2017;67(1):51-64.
3 Tuan JK, Ha TC, Ong WS, et al. Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma. Radiother Oncol . 2012-09-01 2012;104(3):305-311.
4 Yeh SA, Tang Y, Lui CC, Huang YJ, Huang EY. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys . 2005-07-01 2005;62(3):672-679.
5 Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys . 1992-01-19 1992;23(2):261-270.
6 Setton J, Han J, Kannarunimit D, et al. Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma. Oral Oncol . 2016-02-01 2016;53:67-73.
7 Peng G, Wang T, Yang KY, et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol . 2012-09-01 2012;104(3):286-293.
8 Sun X, Su S, Chen C, et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol . 2014-03-01 2014;110(3):398-403.
9 Wei WI. Salvage surgery for recurrent primary nasopharyngeal carcinoma.Crit Rev Oncol Hematol . 2000-02-01 2000;33(2):91-98.
10 Fee WJ, Moir MS, Choi EC, Goffinet D. Nasopharyngectomy for recurrent nasopharyngeal cancer: a 2- to 17-year follow-up. Arch Otolaryngol Head Neck Surg . 2002-03-01 2002;128(3):280-284.
11 King WW, Ku PK, Mok CO, Teo PM. Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: a twelve-year experience. Head Neck . 2000-05-01 2000;22(3):215-222.
12 Vlantis AC, Chan HS, Tong MC, Yu BK, Kam MK, van Hasselt CA. Surgical salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma: a multivariate analysis of prognostic factors. Head Neck . 2011-08-01 2011;33(8):1126-1131.
13 Chan JY. Surgical management of recurrent nasopharyngeal carcinoma.Oral Oncol . 2014-10-01 2014;50(10):913-917.
14 Leung TW, Tung SY, Sze WK, Sze WM, Wong VY, O SK. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys . 2000-05-01 2000;47(2):405-412.
15 Li JX, Lu TX, Huang Y, Han F. Clinical characteristics of recurrent nasopharyngeal carcinoma in high-incidence area.ScientificWorldJournal . 2012-01-20 2012;2012:719754.
16 Oksuz DC, Meral G, Uzel O, Cagatay P, Turkan S. Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys . 2004-10-01 2004;60(2):388-394.
17 Hwang JM, Fu KK, Phillips TL. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys . 1998-07-15 1998;41(5):1099-1111.
18 Qiu S, Lu J, Zheng W, et al. Advantages of intensity modulated radiotherapy in recurrent T1-2 nasopharyngeal carcinoma: a retrospective study.Bmc Cancer . 2014-11-03 2014;14:797.
19 Kong F, Zhou J, Du C, et al. Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.Bmc Cancer . 2018-11-20 2018;18(1):1139.
20 Hua YJ, Han F, Lu LX, et al. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy. Eur J Cancer . 2012-12-01 2012;48(18):3422-3428.
21 Han F, Zhao C, Huang SM, et al. Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol) . 2012-10-01 2012;24(8):569-576.
22 Xiao W, Liu S, Tian Y, et al. Prognostic significance of tumor volume in locally recurrent nasopharyngeal carcinoma treated with salvage intensity-modulated radiotherapy. Plos One . 2015-01-20 2015;10(4):e125351.
23 Han F, Zhao C, Huang SM, et al. Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol) . 2012-10-01 2012;24(8):569-576.
24 Ho AS, Zumsteg ZS, Meyer A, et al. Impact of Flap Reconstruction on Radiotoxicity After Salvage Surgery and Reirradiation for Recurrent Head and Neck Cancer. Ann Surg Oncol . 2016-12-01 2016;23(Suppl 5):850-857.
25 Chan OS, Sze HC, Lee MC, et al. Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma.Head Neck . 2017-03-01 2017;39(3):533-540.
26 Eekers D, Roelofs E, Jelen U, et al. Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial. Radiother Oncol . 2016-12-01 2016;121(3):387-394.
27 Wang JJ, Yuan HS, Li JN, Jiang YL, Tian SQ, Yang RJ. CT-guided radioactive seed implantation for recurrent rectal carcinoma after multiple therapy.Med Oncol . 2010-06-01 2010;27(2):421-429.
28 Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys . 1995-03-30 1995;31(5):1341-1346.
29 Lee AW, Ma BB, Ng WT, Chan AT. Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective. J Clin Oncol . 2015-10-10 2015;33(29):3356-3364.
30 Chua M, Wee J, Hui EP, Chan A. Nasopharyngeal carcinoma. Lancet . 2016-03-05 2016;387(10022):1012-1024.
31 Au KH, Ngan R, Ng A, et al. Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study). Oral Oncol . 2018-02-01 2018;77:16-21.
32 Lee A, Ng WT, Chan J, et al. Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat Rev . 2019-09-01 2019;79:101890.
33 Ng WT, Lee MC, Hung WM, et al. Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma.Int J Radiat Oncol Biol Phys . 2011-02-01 2011;79(2):420-428.
34 Li JX, Huang SM, Jiang XH, et al. Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy.Radiat Oncol . 2014-03-27 2014;9:87.
35 Li JC, Hu CS, Jiang GL, et al. Dose escalation of three-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma: a prospective randomised study. Clin Oncol (R Coll Radiol) . 2006-05-01 2006;18(4):293-299.
36 Koutcher L, Lee N, Zelefsky M, et al. Reirradiation of locally recurrent nasopharynx cancer with external beam radiotherapy with or without brachytherapy. Int J Radiat Oncol Biol Phys . 2010-01-01 2010;76(1):130-137.
37 Teo PM, Kwan WH, Chan AT, Lee WY, King WW, Mok CO. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys . 1998-03-01 1998;40(4):897-913.
38 Li L, Yang J, Li X, et al. (125)I Seed Permanent Implantation as a Palliative Treatment for Stage III and IV Hypopharyngeal Carcinoma.Clin Exp Otorhinolaryngol . 2016-09-01 2016;9(3):185-191.
39 Liu SM, Wang HB, Sun Y, et al. The efficacy of iodine-125 permanent brachytherapy versus intensity-modulated radiation for inoperable salivary gland malignancies: study protocol of a randomised controlled trial. Bmc Cancer . 2016-03-07 2016;16:193.
40 Ji Z, Jiang Y, Tian S, et al. The Effectiveness and Prognostic Factors of CT-guided Radioactive Iodine-125 Seed Implantation for the Treatment of Recurrent Head and Neck Cancer after External Beam Radiotherapy.Int J Radiat Oncol Biol Phys . 2018-11-01 2018.
41 Jiang YL, Meng N, Wang JJ, et al. CT-guided iodine-125 seed permanent implantation for recurrent head and neck cancers. Radiat Oncol . 2010-07-30 2010;5:68.
42 Zhu L, Jiang Y, Wang J, et al. An investigation of 125I seed permanent implantation for recurrent carcinoma in the head and neck after surgery and external beam radiotherapy. World J Surg Oncol . 2013-03-08 2013;11:60.
43 Shen X, Li Y, Zhang Y, Kong J, Li Y. An analysis of brachytherapy with computed tomography-guided permanent implantation of Iodine-125 seeds for recurrent nonkeratin nasopharyngeal carcinoma. Onco Targets Ther . 2015-01-20 2015;8:991-997.
44 Huang H, Xu S, Li F, Du Z, Wang L. Clinical application of computed tomography-guided (125)I seed interstitial implantation for head and neck cancer patients with unmanageable cervical lymph node metastases.Eur J Med Res . 2016-04-27 2016;21:18.
45 Yan H, Mo Z, Xiang Z, et al. CT-guided (125)I brachytherapy for locally recurrent nasopharyngeal carcinoma. J Cancer . 2017-01-20 2017;8(11):2104-2113.
46 Jiang P, Wang J, Ran W, Jiang Y, Tian S, Sun H. Five-year outcome of ultrasound-guided interstitial permanent (125)I seeds implantation for local head and neck recurrent tumors: a single center retrospective study. J Contemp Brachytherapy . 2019-02-01 2019;11(1):28-34.
47 Wang J, Zhang F, Guo J, et al. Expert consensus workshop report: Guideline for three-dimensional printing template-assisted computed tomography-guided (125)I seeds interstitial implantation brachytherapy.J Cancer Res Ther . 2017-01-20 2017;13(4):607-612.
48 Ji Z, Jiang Y, Guo F, et al. Dosimetry verification of radioactive seed implantation for malignant tumors assisted by 3D printing individual templates and CT guidance. Appl Radiat Isot . 2017-06-01 2017;124:68-74.